Elite Pharmaceuticals Inc. (OTCMKTS:ELTP - Get Free Report)'s stock price gapped down prior to trading on Monday . The stock had previously closed at $0.52, but opened at $0.50. Elite Pharmaceuticals shares last traded at $0.50, with a volume of 282,520 shares trading hands.
Elite Pharmaceuticals Price Performance
The company has a quick ratio of 3.50, a current ratio of 4.88 and a debt-to-equity ratio of 0.08. The company has a fifty day simple moving average of $0.59 and a 200-day simple moving average of $0.51.
Elite Pharmaceuticals (OTCMKTS:ELTP - Get Free Report) last issued its earnings results on Monday, June 30th. The specialty pharmaceutical company reported $0.01 earnings per share (EPS) for the quarter. The company had revenue of $32.00 million during the quarter. Elite Pharmaceuticals had a positive return on equity of 3.96% and a negative net margin of 5.13%.
Elite Pharmaceuticals Company Profile
(
Get Free Report)
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
Further Reading
Before you consider Elite Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elite Pharmaceuticals wasn't on the list.
While Elite Pharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
